miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun

Hypertrophic cardiomyopathy (HCM) is a serious monogenic disease characterized by cardiac hypertrophy, fibrosis, sudden cardiac death, and heart failure. Previously, we identified that was down-regulated in HCM patients. However, the regulatory effects of remain unclear. Thus, we investigated the ro...

Full description

Saved in:
Bibliographic Details
Published in:Bioscience reports 2018-04, Vol.38 (2)
Main Authors: Ming, Su, Shui-Yun, Wang, Wei, Qiu, Jian-Hui, Li, Ru-Tai, Hui, Lei, Song, Mei, Jia, Hui, Wang, Ji-Zheng, Wang
Format: Article
Language:English
Subjects:
Animals
Cardiomegaly - chemically induced
Cardiomegaly - genetics
Cardiomegaly - metabolism
Cardiomegaly - pathology
Female
Gene Expression Regulation - drug effects
Gene Expression Regulation - genetics
Gene Knockdown Techniques
Humans
Isoproterenol - adverse effects
Isoproterenol - pharmacology
Male
MicroRNAs - genetics
MicroRNAs - metabolism
Proto-Oncogene Proteins c-jun - biosynthesis
Proto-Oncogene Proteins c-jun - genetics
Rats
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hypertrophic cardiomyopathy (HCM) is a serious monogenic disease characterized by cardiac hypertrophy, fibrosis, sudden cardiac death, and heart failure. Previously, we identified that was down-regulated in HCM patients. However, the regulatory effects of remain unclear. Thus, we investigated the role of in the regulation of cardiac hypertrophy. The expression of in left ventricular tissues in HCM patients and mice subjected to transverse aortic constriction (TAC) was significantly down-regulated. Knockdown of expression in neonatal rat cardiomyocytes (NRCMs) induced cardiomyocyte enlargement and increased atrial natriuretic polypeptide (ANP) expression. Overexpression of antagonized isoproterenol (ISO)-induced cardiomyocyte enlargement and ANP/brain natriuretic peptide (BNP) up-regulation. More importantly, we found that c-Jun expression was inhibited by in NRCMs. Knockdown of c-Jun expression significantly attenuated cardiac hypertrophy induced by deprivation. Our data indicated that was down-regulated in the hearts of HCM patients and that it inhibited cardiac hypertrophy by targetting c-Jun expression.
ISSN:0144-8463
1573-4935
DOI:10.1042/BSR20171430